Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schulze-Koops

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Zeitschrift Fur Rheumatologie|December 6, 2011
[Th1, Th17 and Th1+17 cells]H-D Chang, T Kamradt, H Schulze-Koops
Trends in Immunology|June 23, 2001
Chicken and egg in autoimmunity and joint inflammationH Burkhardt, J R Kalden, H Schulze-Koops
Modern Rheumatology|January 7, 2014
Leflunomide: an immunosuppressive drug with multiple effects on T cell functionP Dimitrova, J R Kalden, H Schulze-Koops
Current Topics in Microbiology and Immunology|May 27, 2006
T cell activation as starter and motor of rheumatic inflammationA Skapenko, P E Lipsky, H Schulze-Koops
Zeitschrift Fur Rheumatologie|April 2, 2009
[Cellular therapy in autoimmune disease]K Thümmler, A Ramming, H Schulze-Koops, et al.
Der Internist|May 3, 2013
[Inflammatory aortic diseases]M Czihal, A Schröttle, H Schulze-Koops, et al.
European Journal of Immunology|August 26, 1998
Human memory T cell differentiation into Th2-like effector cells is dependent on IL-4 and CD28 stimulation and inhibited by TCR ligationH Schulze-Koops, P E Lipsky, L S Davis
Immunologic Research|June 22, 1999
Human CD4+ T cell differentiation and effector function: implications for autoimmunityL S Davis, H Schulze-Koops, P E Lipsky
Zeitschrift Fur Rheumatologie|August 21, 2010
[New biologics and orally available compounds. What is still in the pipeline?]M Grünke, H Bastian, H Schulze-Koops, et al.
Annals of the Rheumatic Diseases|October 1, 1995
Treatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: a pilot study in two childrenG Horneff, U Dirksen, H Schulze-Koops, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Zeitschrift Fur Rheumatologie|December 6, 2011
[Th1, Th17 and Th1+17 cells]H-D Chang, T Kamradt, H Schulze-Koops
Trends in Immunology|June 23, 2001
Chicken and egg in autoimmunity and joint inflammationH Burkhardt, J R Kalden, H Schulze-Koops
Modern Rheumatology|January 7, 2014
Leflunomide: an immunosuppressive drug with multiple effects on T cell functionP Dimitrova, J R Kalden, H Schulze-Koops
Current Topics in Microbiology and Immunology|May 27, 2006
T cell activation as starter and motor of rheumatic inflammationA Skapenko, P E Lipsky, H Schulze-Koops
Zeitschrift Fur Rheumatologie|April 2, 2009
[Cellular therapy in autoimmune disease]K Thümmler, A Ramming, H Schulze-Koops, et al.
Der Internist|May 3, 2013
[Inflammatory aortic diseases]M Czihal, A Schröttle, H Schulze-Koops, et al.
European Journal of Immunology|August 26, 1998
Human memory T cell differentiation into Th2-like effector cells is dependent on IL-4 and CD28 stimulation and inhibited by TCR ligationH Schulze-Koops, P E Lipsky, L S Davis
Immunologic Research|June 22, 1999
Human CD4+ T cell differentiation and effector function: implications for autoimmunityL S Davis, H Schulze-Koops, P E Lipsky
Zeitschrift Fur Rheumatologie|August 21, 2010
[New biologics and orally available compounds. What is still in the pipeline?]M Grünke, H Bastian, H Schulze-Koops, et al.
Annals of the Rheumatic Diseases|October 1, 1995
Treatment of refractory juvenile chronic arthritis by monoclonal CD4 antibodies: a pilot study in two childrenG Horneff, U Dirksen, H Schulze-Koops, et al.
Pageof 11